Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India

Back Stocks profile

Stock analysis tool for investors

Zenith Drugs Ltd.

NSE: ZENITHDRUG | BSE:

₹137.00 5.85 (4.46%) 1D

Pharmaceuticals & Biotechnology

Buy Sell
Open free demat account

Open an Account with Bigul in 5 minutes

Performance Online share trading app

Today’s low

131.20

Today’s High

138.50

52W low

52.80

52W High

147.50

Open Price

131.20

Prev. Close

135.6500

Volume

16000.00

Value

2192000.00

Fundamentals Open free demat account

Market Cap

234.90

Price to Earnings

0.00

Price to Book Value

3.80

Dividend Yield

0.00

PE to Growth

0.00

Op Revenue TTM

0.00

Net Profit TTM

0.00

Cash From Operating Activity

-13.01

Return on Equity %

15.40

EMA & SMA

Online share trading app Open free demat account

Bullish Moving Averages

13

Bearish Moving Averages

0

5Day EMA

132.3

10Day EMA

126.5

12Day EMA

124.1

20Day EMA

116.2

26Day EMA

111.5

50Day EMA

99.1

100Day EMA

87.6

EMA

5Day SMA

136.1

10Day SMA

125

20Day SMA

114.2

30Day SMA

103.3

50Day SMA

94

100Day SMA

79.4

SMA

SMA

DELIVERY AND VOLUME

DAILY AVG. DELIVERY VOLUME %

18 Sep, 2024

64.8

Week

58.8

Month

65.5

LEGEND

Positive Indicator

Neutral Indicator

Negative Indicator

RESISTANCE AND SUPPORT

131.33

PIVOT

First Resistance

134.67

Second Resistance

138.18

Third Resistance

141.52

First Support

127.82

Second Support

124.48

Third Support

120.97

Relative Strength Index

66.63

Money Flow Index

62.02

MACD

12.64

MACD Signal

10.81

Average True Range

8.71

Average Directional Index

45.61

Rate of Change (21)

65.28

Rate of Change (125)

102.39

Day Commodity Channel Index

92.6

Day Williams %R

-36.7

BETA

1 Month

3.1

3 Month

1.56

1 Year

3 Year

PRICE CHANGE ANALYSIS

↑ 6.99%

1 Week

Low

High

128

147.5

↑ 63.39%

1 Month

Low

High

78.3

147.5

↑ 116.09%

3 Months

Low

High

62

147.5

↑ 105.4%

6 Months

Low

High

52.8

147.5

↑ 73.42%

1 Year

Low

High

52.8

147.5

Indicator Graph
Total Qtr Revenue cr
Operating Expenses Qtr
Operating Profit Qtr
EBIDT Qtr Cr
Depreciation Qtr
Net Profit Qtr
Basic EPS Qtr
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total Revenue Annual 133.74 115.76 92.60 73.52 78.33
Operating Expenses Annual Cr 114.70 105.47 84.73 66.20 71.23
Operating Profit Annual 16.92 9.05 6.92 7.20 7.05
Operating Profit Margin Annual % 12.65 7.82 7.48 9.79 8.99
Total Expenses Annual Cr 119.00 109.10 88.20 68.92 73.46
EBIDT Annual Cr 19.04 10.29 7.87 7.31 7.11
EBIDT Annual margin % 14.24 8.89 8.50 9.95 9.07
Depreciation 1.30 1.30 1.34 1.22 0.92
PAT Before ExtraOrdinary Items Annual Cr 9.54 4.88 3.21 3.07 3.40
Net Profit Annual 9.54 4.88 3.21 3.07 3.40
Basic EPS Annual 122.03 5.56 80.32 76.66 85.00
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total ShareHolders Funds Annual 62.22 17.73 12.85 9.64 6.57
Minority Interest Liability Annual Cr - - - - -
Total Non Current Liabilities Annual Cr 7.85 7.84 7.81 7.55 9.73
Total Current Liabilities Annual Cr 64.10 71.65 45.53 29.35 27.42
Total Capital Plus Liabilities Annual Cr 134.17 97.22 66.18 46.54 43.72
Fixed Assets Annual 14.85 10.82 10.45 9.21 9.01
Total Non Current Assets Annual 21.34 13.14 12.40 10.69 9.01
Total Current Assets Annual 112.84 84.08 53.79 35.85 34.72
Total Assets Annual 134.17 97.22 66.18 46.54 43.72
Contingent Liabilities plus Commitments Annual Cr - - 0.00 0.00 0.00
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Cash from Operating Activity Annual 0.00 0.00 4.91 -0.89 3.48
Cash from Investing Activity Annual 0.00 0.00 2.61 -1.43 -4.93
Cash from Financing Annual Activity 0.00 0.00 -0.83 2.88 1.36
Net Cash Flow Annual - - 6.69 0.57 -0.09
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Book Value Per Share Annual 36.28 443.30 321.27 240.95 164.29
ROE Annual % 15.32 27.52 25.00 31.81 51.73
ROCE Annual % 25.31 35.13 31.63 35.43 37.96
Total Debt to Total Equity Annual 0.38 1.43 1.31 1.61 1.84
EBDIT Annual Margin % 14.46 8.98 8.58 9.96 9.08
Indicator Graph
Total Qtr Revenue cr
Operating Expenses Qtr
Operating Profit Qtr
EBIDT Qtr Cr
Depreciation Qtr
Net Profit Qtr
Basic EPS Qtr
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Graph
Total Revenue Annual 133.74 115.70 92.67 73.52
Operating Expenses Annual Cr 114.70 104.85 84.82 66.37
Operating Profit Annual 16.92 9.67 6.83 7.03
Operating Profit Margin Annual % 12.65 8.36 7.37 9.56
Total Expenses Annual Cr 119.00 108.49 88.26 68.91
EBIDT Annual Cr 19.04 10.85 7.84 7.14
EBIDT Annual margin % 14.23 9.38 8.46 9.72
Depreciation 1.30 1.30 1.33 1.22
PAT Before ExtraOrdinary Items Annual Cr 9.65 5.15 3.13 3.03
Net Profit Annual 9.59 5.15 3.14 3.03
Basic EPS Annual 6.91 128.82 78.22 75.73
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Graph
Total ShareHolders Funds Annual 62.26 17.24 12.09 8.95
Minority Interest Liability Annual Cr 0.07 0.01 0.01 0.00
Total Non Current Liabilities Annual Cr 8.56 8.86 9.90 7.62
Total Current Liabilities Annual Cr 64.15 71.82 46.58 29.97
Total Capital Plus Liabilities Annual Cr 135.04 97.94 68.58 46.55
Fixed Assets Annual 15.25 11.73 13.13 9.22
Total Non Current Assets Annual 21.71 14.02 15.05 10.70
Total Current Assets Annual 113.33 83.92 53.53 35.85
Total Assets Annual 135.04 97.94 68.58 46.55
Contingent Liabilities plus Commitments Annual Cr - 0.25 0.00 0.00
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Graph
Cash from Operating Activity Annual -13.01 -4.41 5.15 0.76
Cash from Investing Activity Annual 26.00 0.11 -5.24 -1.43
Cash from Financing Annual Activity -4.47 4.91 1.24 2.08
Net Cash Flow Annual 8.52 0.61 1.15 1.41
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Graph
Book Value Per Share Annual 36.35 431.47 302.64 223.82
ROE Annual % 15.40 29.88 25.95 33.83
ROCE Annual % 25.01 36.54 29.60 35.75
Total Debt to Total Equity Annual 0.40 1.51 1.56 1.73
EBDIT Annual Margin % 14.46 9.47 8.55 9.73
Name Holding Percent Holding Id Pledged % Locked %
Name Holding Percent Holding Id Pledged % Locked %
AJAY SINGH DASSUNDI 22.52 75290256 0 100
SANDEEP BHARDWAJ 21.38 75290257 0 100
BHUPESH SONI 20.18 75290260 0 100
JAYWANTI SONI 2.94 75290262 0 100
PRIYANKA BHARADWAJ 1.94 75290259 0 100
ANJALI DASSUNDI 0.8 75290258 0 100
Name Holding Percent Holding Id
MERU INVESTMENT FUND PCC-CELL 1 2.2 75290268
ARIES OPPORTUNITIES FUND LIMITED 1.47 75290267
VIKASA INDIA EIF I FUND - ZODIAC GLOBAL OPPORTUNITY FUND 1.23 75290269
NEOMILE GROWTH FUND - SERIES I 1.11 75290265
Name Holding Percent Holding Id
PRAVEEN MUDUNURI 1.11 75290273
GRETEX SHARE BROKING LIMITED 3.47 75290276
YUGA STOCKS AND COMMODITIES PRIVATE LIMITED 1.17 75290277
Ex-Date Dividend Amount Dividend Type Record Date Instrument Type
Ex-Date Split Ratio Record Date
Ex-Date Purpose Notes
May 29, 2024 Audited Results -
Ex-Date Bonus Ratio Record Date

FAQs

Investment Platform in India

The latest market price of Zenith Drugs Ltd. on NSE was Rs. 137.00 as of today.

The opening share price of Zenith Drugs Ltd. was Rs. 131.20 as of today.

The 52-week high share price of Zenith Drugs Ltd. was Rs. 147.50.

The 52 week low share price of Zenith Drugs Ltd. was Rs. 52.80.

Please find Corporate actions section for more details.

The PE ratio of Zenith Drugs Ltd. is 0.00. Please refer to the Fundamentals section for further details.

Please find Corporate actions section for more details.

Please find Corporate actions section for more details.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please find Corporate actions section for more details.

Please find Corporate actions section for more details.

Please find Corporate actions section for more details.

Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.

Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.

Please refer to the News section for the latest news about Zenith Drugs Ltd..

Investment Platform in India
Close

Let's Open Free Demat Account